IC
CHRS icon

IEQ Capital’s Coherus Oncology CHRS Stock Holding History

IEQ Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Buy
162,353
+40,386
+33% +$65.9K ﹤0.01% 1772
2026
Q1 		$206K Buy
121,967
+42,839
+54% +$76.1K ﹤0.01% 1690
2025
Q4 		$112K Buy
79,128
+15,751
+25% +$23K ﹤0.01% 1753
2025
Q3 		$104K Sell
63,377
-13,903
-18% -$15.5K ﹤0.01% 1764
2025
Q2 		$56.5K Buy
77,280
+2,260
+3% +$1.95K ﹤0.01% 1756
2025
Q1 		$60.5K Buy
75,020
+25,837
+53% +$29.7K ﹤0.01% 1537
2024
Q4 		$67.9K Buy
+49,183
New +$55.2K ﹤0.01% 1284

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

IEQ Capital's CHRS Position: Q2 2026 in Review

IEQ Capital increased its Coherus Oncology (CHRS) stake by 33% in Q2 2026, buying an estimated $65.9K and bringing the position to 162,353 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.

IEQ Capital first reported a position in CHRS in Q4 2024 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • IEQ Capital held 162,353 shares of Coherus Oncology worth $227K as of Q2 2026.
  • IEQ Capital bought 40,386 Coherus Oncology shares in Q2 2026, an estimated $65.9K.
  • Coherus Oncology made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1772 holding.
  • IEQ Capital first reported a position in Coherus Oncology in Q4 2024 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.